Magnetic resonance imaging: A potential tool in assessing the addition of hyperthermia to neoadjuvant therapy in patients with locally advanced breast cancer

References

• Honkoop AH, van Diest PJ, de Jong JS, Linn SC, Giaccone G, Hoekman K, Wagstaff J, Pinedo HM. Prognostic role of clinical, pathological and biological characteristics in patients with locally advanced breast cancer. Br J Cancer 1998; 77(4)621–626
   PubMed Web of Science ®Google Scholar
• Swain SM, Sorace RA, Bagley CS, Danforth DN, Jr, Bader J, Wesley MN, Steinberg SM, Lippman ME. Neoadjuvant chemotherapy in the combined modality approach of locally advanced nonmetastatic breast cancer. Cancer Res 1987; 47(14)3889–3894
   PubMed Web of Science ®Google Scholar
• Sataloff DM, Mason BA, Prestipino AJ, Seinige UL, Lieber CP, Baloch Z. Pathologic response to induction chemotherapy in locally advanced carcinoma of the breast: A determinant of outcome. J Am Coll Surg 1995; 180(3)297–306
   PubMed Web of Science ®Google Scholar
• Lerebours F, Bieche I, Lidereau R. Update on inflammatory breast cancer. Breast Cancer Res 2005; 7(2)52–58
   PubMed Web of Science ®Google Scholar
• Rastogi P, Anderson SJ, Bear HD, Geyer CE, Kahlenberg MS, Robidoux A, Margolese RG, Hoehn JL, Vogel VG, Dakhil SR, et al. Preoperative chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27. J Clin Oncol 2008; 26(5)778–785
   PubMed Web of Science ®Google Scholar
• Bonadonna G, Valagussa P, Brambilla C, Ferrari L, Moliterni A, Terenziani M, Zambetti M. Primary chemotherapy in operable breast cancer: Eight-year experience at the Milan Cancer Institute. J Clin Oncol 1998; 16(1)93–100
   PubMed Web of Science ®Google Scholar
• Bear HD, Anderson S, Brown A, Smith R, Mamounas EP, Fisher B, Margolese R, Theoret H, Soran A, Wickerham DL, et al. The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: Preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol 2003; 21(22)4165–4174
   PubMed Web of Science ®Google Scholar
• Makris A, Powles TJ, Ashley SE, Chang J, Hickish T, Tidy VA, Nash AG, Ford HT. A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer. Ann Oncol 1998; 9(11)1179–1184
   PubMed Web of Science ®Google Scholar
• Mauri D, Pavlidis N, Ioannidis JP. Neoadjuvant versus adjuvant systemic treatment in breast cancer: A meta-analysis. J Natl Cancer Inst 2005; 97(3)188–194
   PubMedGoogle Scholar
• Mieog JS, van der Hage JA, van de Velde CJ. Neoadjuvant chemotherapy for operable breast cancer. Br J Surg 2007; 94(10)1189–1200
   PubMed Web of Science ®Google Scholar
• Vujaskovic Z, Kim DW, Jones E, Lan L, McCall L, Dewhirst DW, Craciunescu O, Stauffer P, Liotcheva V, Betof A, Blackwell K. A Phase I/II Study of Neoadjuvant Liposomal Doxorubicin, Paclitaxel, and Hyperthermia in Locally Advanced Breast Cancer. International Journal of Hyperthermia 2010; 26(5)514–521
   PubMed Web of Science ®Google Scholar
• Vujaskovic Z, Song CW. Physiological mechanisms underlying heat-induced radiosensitization. Int J Hyperthermia 2004; 20(2)163–174
   PubMed Web of Science ®Google Scholar
• Dewhirst MW, Vujaskovic Z, Jones E, Thrall D. Re-setting the biologic rationale for thermal therapy. Int J Hyperthermia 2005; 21(8)779–790
   PubMed Web of Science ®Google Scholar
• Hahn G. Hyperthermia and Cancer. Plenum Press, New York 1982
   Google Scholar
• Kong G, Dewhirst MW. Hyperthermia and liposomes. Int J Hyperthermia 1999; 15(5)345–370
   PubMed Web of Science ®Google Scholar
• Matteucci ML, Anyarambhatla G, Rosner G, Azuma C, Fisher PE, Dewhirst MW, Needham D, Thrall DE. Hyperthermia increases accumulation of technetium-99m-labeled liposomes in feline sarcomas. Clin Cancer Res 2000; 6(9)3748–3755
   PubMed Web of Science ®Google Scholar
• Hahn GM, Braun J, Har-Kedar I. Thermochemotherapy: Synergism between hyperthermia (42-43 degrees) and adriamycin (of bleomycin) in mammalian cell inactivation. Proc Natl Acad Sci U S A 1975; 72(3)937–940
   PubMed Web of Science ®Google Scholar
• Herman TS. Temperature dependence of adriamycin, cis-diamminedichloroplatinum, bleomycin, and 1,3-bis(2-chloroethyl)-1-nitrosourea cytotoxicity in vitro. Cancer Res 1983; 43(2)517–520
   PubMed Web of Science ®Google Scholar
• Brewster AM, Hortobagyi GN, Broglio KR, Kau SW, Santa-Maria CA, Arun B, Buzdar AU, Booser DJ, Valero V, Bondy M, et al. Residual risk of breast cancer recurrence 5 years after adjuvant therapy. J Natl Cancer Inst 2008; 100(16)1179–1183
   PubMedGoogle Scholar
• Needham D, Anyarambhatla G, Kong G, Dewhirst MW. A new temperature-sensitive liposome for use with mild hyperthermia: Characterization and testing in a human tumor xenograft model. Cancer Res 2000; 60(5)1197–1201
   PubMed Web of Science ®Google Scholar
• Ponce AM, Vujaskovic Z, Yuan F, Needham D, Dewhirst MW. Hyperthermia mediated liposomal drug delivery. Int J Hyperthermia 2006; 22(3)205–213
   PubMed Web of Science ®Google Scholar
• Kong G, Anyarambhatla G, Petros WP, Braun RD, Colvin OM, Needham D, Dewhirst MW. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: Importance of triggered drug release. Cancer Res 2000; 60(24)6950–6957
   PubMed Web of Science ®Google Scholar
• Chen Q, Krol A, Wright A, Needham D, Dewhirst MW, Yuan F. Tumor microvascular permeability is a key determinant for antivascular effects of doxorubicin encapsulated in a temperature sensitive liposome. Int J Hyperthermia 2008; 24(6)475–482
   PubMed Web of Science ®Google Scholar
• Mansour JC, Schwarz RE. Molecular mechanisms for individualized cancer care. J Am Coll Surg 2008; 207(2)250–258
   PubMed Web of Science ®Google Scholar
• Basu S, Kumar R, Rubello D, Fanti S, Alavi A. PET imaging in neuroendocrine tumors: Current status and future prospects. Minerva Endocrinol 2008; 33(3)257–275
   PubMed Web of Science ®Google Scholar
• Mohan HK, Miles KA. Cost-effectiveness of 99mTc-sestamibi in predicting response to chemotherapy in patients with lung cancer: Systematic review and meta-analysis. J Nucl Med 2009; 50(3)376–381
   PubMed Web of Science ®Google Scholar
• Birdwell RL, Mountford CE, Iglehart JD. Molecular imaging of the breast. AJR Am J Roentgenol 2009; 193(2)367–376
   PubMed Web of Science ®Google Scholar
• Sinha S, Sinha U. Recent advances in breast MRI and MRS. NMR Biomed 2009; 22(1)3–16
   PubMed Web of Science ®Google Scholar
• Leach MO, Brindle KM, Evelhoch JL, Griffiths JR, Horsman MR, Jackson A, Jayson GC, Judson IR, Knopp MV, Maxwell RJ, et al. The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: Issues and recommendations. Br J Cancer 2005; 92(9)1599–1610
   PubMed Web of Science ®Google Scholar
• Glunde KJM, Pathak AP, Artemov D, Bhujwalla ZM. Molecular and functional imaging of breast cancer. NMR Biomed 2008; 22(1)92–103
   Web of Science ®Google Scholar
• Ikeda DM, Hylton NM, Kinkel K, Hochman MG, Kuhl CK, Kaiser WA, Weinreb JC, Smazal SF, Degani H, Viehweg P, et al. Development, standardization, and testing of a lexicon for reporting contrast-enhanced breast magnetic resonance imaging studies. J Magn Reson Imaging 2001; 13(6)889–895
   PubMed Web of Science ®Google Scholar
• Knopp MV, Weiss E, Sinn HP, Mattern J, Junkermann H, Radeleff J, Magener A, Brix G, Delorme S, Zuna I, et al. Pathophysiologic basis of contrast enhancement in breast tumors. J Magn Reson Imaging 1999; 10(3)260–266
   PubMed Web of Science ®Google Scholar
• Knopp MV, von Tengg-Kobligk H, Choyke PL. Functional magnetic resonance imaging in oncology for diagnosis and therapy monitoring. Mol Cancer Ther 2003; 2(4)419–426
   PubMed Web of Science ®Google Scholar
• Padhani AR, Hayes C, Assersohn L, Powles T, Makris A, Suckling J, Leach MO, Husband JE. Prediction of clinicopathologic response of breast cancer to primary chemotherapy at contrast-enhanced MR imaging: Initial clinical results. Radiology 2006; 239(2)361–374
   PubMed Web of Science ®Google Scholar
• Wedam SB, Low JA, Yang SX, Chow CK, Choyke P, Danforth D, Hewitt SM, Berman A, Steinberg SM, Liewehr DJ, et al. Antiangiogenic and antitumor effects of bevacizumab in patients with inflammatory and locally advanced breast cancer. J Clin Oncol 2006; 24(5)769–777
   PubMed Web of Science ®Google Scholar
• Kuhl CK, Schild HH, Morakkabati N. Dynamic bilateral contrast-enhanced MR imaging of the breast: Trade-off between spatial and temporal resolution. Radiology 2005; 236(3)789–800
   PubMed Web of Science ®Google Scholar
• Parker GJM, Buckley DL. Tracer kinetic modelling for T1-weighted DCE-MRI. Dynamic Contrast Enhanced Magneric Resonance Imaging in Oncology, A Jackson, DL Buckley, GJM Parker. Springer, Berlin Heidelberg 2005; 81–92
   Google Scholar
• Furman-Haran E, Schechtman E, Kelcz F, Kirshenbaum K, Degani H. Magnetic resonance imaging reveals functional diversity of the vasculature in benign and malignant breast lesions. Cancer 2005; 104(4)708–718
   PubMed Web of Science ®Google Scholar
• Turnbull LW, Buckley DL, Turnbull LS, Liney GP, Knowles AJ. Differentiation of prostatic carcinoma and benign prostatic hyperplasia: Correlation between dynamic Gd-DTPA-enhanced MR imaging and histopathology. J Magn Reson Imaging 1999; 9(2)311–316
   PubMed Web of Science ®Google Scholar
• O'Connor JP, Jackson A, Parker GJ, Jayson GC. DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents. Br J Cancer 2007; 96(2)189–195
   PubMed Web of Science ®Google Scholar
• Roberts TP. Physiologic measurements by contrast-enhanced MR imaging: Expectations and limitations. J Magn Reson Imaging 1997; 7(1)82–90
   PubMed Web of Science ®Google Scholar
• Beauregard DA, Thelwall PE, Chaplin DJ, Hill SA, Adams GE, Brindle KM. Magnetic resonance imaging and spectroscopy of combretastatin A4 prodrug-induced disruption of tumour perfusion and energetic status. Br J Cancer 1998; 77(11)1761–1767
   PubMed Web of Science ®Google Scholar
• Mayr NA, Yuh WT, Magnotta VA, Ehrhardt JC, Wheeler JA, Sorosky JI, Davis CS, Wen BC, Martin DD, Pelsang RE, et al. Tumor perfusion studies using fast magnetic resonance imaging technique in advanced cervical cancer: A new noninvasive predictive assay. Int J Radiat Oncol Biol Phys 1996; 36(3)623–633
   PubMed Web of Science ®Google Scholar
• Hawighorst H, Libicher M, Knopp MV, Moehler T, Kauffmann GW, Kaick G. Evaluation of angiogenesis and perfusion of bone marrow lesions: Role of semiquantitative and quantitative dynamic MRI. J Magn Reson Imaging 1999; 10(3)286–294
   PubMed Web of Science ®Google Scholar
• Larson KB, Markham J, Raichle ME. Tracer-kinetic models for measuring cerebral blood flow using externally detected radiotracers. J Cereb Blood Flow Metab 1987; 7(4)443–463
   PubMed Web of Science ®Google Scholar
• Brix G, Semmler W, Port R, Schad LR, Layer G, Lorenz WJ. Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging. J Comput Assist Tomogr 1991; 15(4)621–628
   PubMed Web of Science ®Google Scholar
• Tofts PS, Berkowitz B, Schnall MD. Quantitative analysis of dynamic Gd-DTPA enhancement in breast tumors using a permeability model. Magn Reson Med 1995; 33(4)564–568
   PubMed Web of Science ®Google Scholar
• Tofts PS. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging 1997; 7(1)91–101
   PubMed Web of Science ®Google Scholar
• Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, Knopp MV, Larsson HB, Lee TY, Mayr NA, Parker GJ, et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: Standardized quantities and symbols. J Magn Reson Imaging 1999; 10(3)223–232
   PubMed Web of Science ®Google Scholar
• Tofts PS, Kermode AG. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts. Magn Reson Med 1991; 17(2)357–367
   PubMed Web of Science ®Google Scholar
• Liu G, Rugo HS, Wilding G, McShane TM, Evelhoch JL, Ng C, Jackson E, Kelcz F, Yeh BM, Lee FT, Jr, et al. Dynamic contrast-enhanced magnetic resonance imaging as a pharmacodynamic measure of response after acute dosing of AG-013736, an oral angiogenesis inhibitor, in patients with advanced solid tumors: Results from a phase I study. J Clin Oncol 2005; 23(24)5464–5473
   PubMed Web of Science ®Google Scholar
• Padhani AR, Gapinski CJ, Macvicar DA, Parker GJ, Suckling J, Revell PB, Leach MO, Dearnaley DP, Husband JE. Dynamic contrast enhanced MRI of prostate cancer: Correlation with morphology and tumour stage, histological grade and PSA. Clin Radiol 2000; 55(2)99–109
   PubMed Web of Science ®Google Scholar
• Stevenson JP, Rosen M, Sun W, Gallagher M, Haller DG, Vaughn D, Giantonio B, Zimmer R, Petros WP, Stratford M, et al. Phase I trial of the antivascular agent combretastatin A4 phosphate on a 5-day schedule to patients with cancer: Magnetic resonance imaging evidence for altered tumor blood flow. J Clin Oncol 2003; 21(23)4428–4438
   PubMed Web of Science ®Google Scholar
• Dale BM, Jesberger JA, Lewin JS, Hillenbrand CM, Duerk JL. Determining and optimizing the precision of quantitative measurements of perfusion from dynamic contrast enhanced MRI. J Magn Reson Imaging 2003; 18(5)575–584
   PubMed Web of Science ®Google Scholar
• Leach MO. Application of magnetic resonance imaging to angiogenesis in breast cancer. Breast Cancer Res 2001; 3(1)22–27
   PubMed Web of Science ®Google Scholar
• Evelhohc JL BT, Chenevert L, editor. Consensus recommendation for acquisition of dynamic contrast enhanced MRI data in oncology. Proceedings of the 8th Annual Meeting International Society for Magnetic Resonance in Medicine, Denver, 2000: 1439.
   Google Scholar
• Evelhoch JL. Key factors in the acquisition of contrast kinetic data for oncology. J Magn Reson Imaging 1999; 10(3)254–259
   PubMed Web of Science ®Google Scholar
• Walker-Samuel S, Leach MO, Collins DJ. Evaluation of response to treatment using DCE-MRI: The relationship between initial area under the gadolinium curve (IAUGC) and quantitative pharmacokinetic analysis. Phys Med Biol 2006; 51(14)3593–3602
   PubMed Web of Science ®Google Scholar
• Padhani AR. Functional MRI for anticancer therapy assessment. Eur J Cancer 2002; 38(16)2116–2127
   PubMed Web of Science ®Google Scholar
• Ludemann L, Wust P, Gellermann J. Perfusion measurement using DCE-MRI: Implications for hyperthermia. Int J Hyperthermia 2008; 24(1)91–96
   PubMed Web of Science ®Google Scholar
• Boehm T, Folkman J, Browder T, O'Reilly MS. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature 1997; 390(6658)404–407
   PubMed Web of Science ®Google Scholar
• Rehman S, Jayson GC. Molecular imaging of antiangiogenic agents. Oncologist 2005; 10(2)92–103
   PubMed Web of Science ®Google Scholar
• Folkman J. What is the evidence that tumors are angiogenesis dependent?. J Natl Cancer Inst 1990; 82(1)4–6
   PubMed Web of Science ®Google Scholar
• Pickles MD, Lowry M, Manton DJ, Gibbs P, Turnbull LW. Role of dynamic contrast enhanced MRI in monitoring early response of locally advanced breast cancer to neoadjuvant chemotherapy. Breast Cancer Res Treat 2005; 91(1)1–10
   PubMed Web of Science ®Google Scholar
• Abraham DC, Jones RC, Jones SE, Cheek JH, Peters GN, Knox SM, Grant MD, Hampe DW, Savino DA, Harms SE. Evaluation of neoadjuvant chemotherapeutic response of locally advanced breast cancer by magnetic resonance imaging. Cancer 1996; 78(1)91–100
   PubMed Web of Science ®Google Scholar
• Martincich L, Montemurro F, De Rosa G, Marra V, Ponzone R, Cirillo S, Gatti M, Biglia N, Sarotto I, Sismondi P, et al. Monitoring response to primary chemotherapy in breast cancer using dynamic contrast-enhanced magnetic resonance imaging. Breast Cancer Res Treat 2004; 83(1)67–76
   PubMed Web of Science ®Google Scholar
• Julius T, Kemp SE, Kneeshaw PJ, Chaturvedi A, Drew PJ, Turnbull LW. MRI and conservative treatment of locally advanced breast cancer. Eur J Surg Oncol 2005; 31(10)1129–1134
   PubMed Web of Science ®Google Scholar
• Wasser K, Klein SK, Fink C, Junkermann H, Sinn HP, Zuna I, Knopp MV, Delorme S. Evaluation of neoadjuvant chemotherapeutic response of breast cancer using dynamic MRI with high temporal resolution. Eur Radiol 2003; 13(1)80–87
   PubMed Web of Science ®Google Scholar
• Drew PJ, Kerin MJ, Mahapatra T, Malone C, Monson JR, Turnbull LW, Fox JN. Evaluation of response to neoadjuvant chemoradiotherapy for locally advanced breast cancer with dynamic contrast-enhanced MRI of the breast. Eur J Surg Oncol 2001; 27(7)617–620
   PubMed Web of Science ®Google Scholar
• Szabo BK, Aspelin P, Kristoffersen Wiberg M, Tot T, Bone B. Invasive breast cancer: Correlation of dynamic MR features with prognostic factors. Eur Radiol 2003; 13(11)2425–2435
   PubMed Web of Science ®Google Scholar
• Chang YC, Huang CS, Liu YJ, Chen JH, Lu YS, Tseng WY. Angiogenic response of locally advanced breast cancer to neoadjuvant chemotherapy evaluated with parametric histogram from dynamic contrast-enhanced MRI. Phys Med Biol 2004; 49(16)3593–3602
   PubMed Web of Science ®Google Scholar
• Baar J, Silverman P, Lyons J, Fu P, Abdul-Karim F, Ziats N, Wasman J, Hartman P, Jesberger J, Dumadag L, et al. A vasculature-targeting regimen of preoperative docetaxel with or without bevacizumab for locally advanced breast cancer: Impact on angiogenic biomarkers. Clin Cancer Res 2009; 15(10)3583–3590
   PubMed Web of Science ®Google Scholar
• Johansen R, Jensen LR, Rydland J, Goa PE, Kvistad KA, Bathen TF, Axelson DE, Lundgren S, Gribbestad IS. Predicting survival and early clinical response to primary chemotherapy for patients with locally advanced breast cancer using DCE-MRI. J Magn Reson Imaging 2009; 29(6)1300–1307
   PubMed Web of Science ®Google Scholar
• Wu F, Wang ZB, Cao YD, Chen WZ, Bai J, Zou JZ, Zhu H. A randomised clinical trial of high-intensity focused ultrasound ablation for the treatment of patients with localised breast cancer. Br J Cancer 2003; 89(12)2227–2233
   PubMed Web of Science ®Google Scholar
• Wu F, Wang ZB, Zhu H, Chen WZ, Zou JZ, Bai J, Li KQ, Jin CB, Xie FL, Su HB. Extracorporeal high intensity focused ultrasound treatment for patients with breast cancer. Breast Cancer Res Treat 2005; 92(1)51–60
   PubMed Web of Science ®Google Scholar
• Furusawa H, Namba K, Thomsen S, Akiyama F, Bendet A, Tanaka C, Yasuda Y, Nakahara H. Magnetic resonance-guided focused ultrasound surgery of breast cancer: Reliability and effectiveness. J Am Coll Surg 2006; 203(1)54–63
   PubMed Web of Science ®Google Scholar
• Craciunescu OI, Blackwell KL, Jones EL, Macfall JR, Yu D, Vujaskovic Z, Wong TZ, Liotcheva V, Rosen EL, Prosnitz LR, et al. DCE-MRI parameters have potential to predict response of locally advanced breast cancer patients to neoadjuvant chemotherapy and hyperthermia: A pilot study. Int J Hyperthermia 2009; 25(6)405–415
   PubMed Web of Science ®Google Scholar
• Craciunescu OI, Jones EL, Blackwell KL, Wong TZ, Rosen EL, Vujaskovic Z, MacFall JR, Liotcheva V, Lora-Michels M, Prosnitz LP, et al. Characterizing tumor changes during neoadjuvant treatment of locally advanced breast cancer patients (LABC) using dynamic-enhanced magnetic resonance imaging (DCE-MRI). SPIE. SPIE Publishing, San Jose 2005
   Google Scholar
• Mukherji SK, Chenevert TL, Castillo M. Diffusion-weighted magnetic resonance imaging. J Neuroophthalmol 2002; 22(2)118–122
   PubMed Web of Science ®Google Scholar
• Chenevert TL, Meyer CR, Moffat BA, Rehemtulla A, Mukherji SK, Gebarski SS, Quint DJ, Robertson PL, Lawrence TS, Junck L, et al. Diffusion MRI: A new strategy for assessment of cancer therapeutic efficacy. Mol Imaging 2002; 1(4)336–343
   PubMedGoogle Scholar
• Sinha S, Sinha U. Functional magnetic resonance of human breast tumors: Diffusion and perfusion imaging. Ann N Y Acad Sci 2002; 980: 95–115
   PubMed Web of Science ®Google Scholar
• Van Zijl PC, Moonen CT, Faustino P, Pekar J, Kaplan O, Cohen JS. Complete separation of intracellular and extracellular information in NMR spectra of perfused cells by diffusion-weighted spectroscopy. Proc Natl Acad Sci U S A 1991; 88(8)3228–3232
   PubMed Web of Science ®Google Scholar
• Horsfield MA, Barker GJ, McDonald WI. Self-diffusion in CNS tissue by volume-selective proton NMR. Magn Reson Med 1994; 31(6)637–644
   PubMed Web of Science ®Google Scholar
• Niendorf T, Dijkhuizen RM, Norris DG, van Lookeren Campagne M, Nicolay K. Biexponential diffusion attenuation in various states of brain tissue: Implications for diffusion-weighted imaging. Magn Reson Med 1996; 36(6)847–857
   PubMed Web of Science ®Google Scholar
• Chenevert TL, Stegman LD, Taylor JM, Robertson PL, Greenberg HS, Rehemtulla A, Ross BD. Diffusion magnetic resonance imaging: An early surrogate marker of therapeutic efficacy in brain tumors. J Natl Cancer Inst 2000; 92(24)2029–2036
   PubMedGoogle Scholar
• Kauppinen RA. Monitoring cytotoxic tumour treatment response by diffusion magnetic resonance imaging and proton spectroscopy. NMR Biomed 2002; 15(1)6–17
   PubMed Web of Science ®Google Scholar
• Lyng H, Haraldseth O, Rofstad EK. Measurement of cell density and necrotic fraction in human melanoma xenografts by diffusion weighted magnetic resonance imaging. Magn Reson Med 2000; 43(6)828–836
   PubMed Web of Science ®Google Scholar
• Guo Y, Cai YQ, Cai ZL, Gao YG, An NY, Ma L, Mahankali S, Gao JH. Differentiation of clinically benign and malignant breast lesions using diffusion-weighted imaging. J Magn Reson Imaging 2002; 16(2)172–178
   PubMed Web of Science ®Google Scholar
• Ross BD, Moffat BA, Lawrence TS, Mukherji SK, Gebarski SS, Quint DJ, Johnson TD, Junck L, Robertson PL, Muraszko KM, et al. Evaluation of cancer therapy using diffusion magnetic resonance imaging. Mol Cancer Ther 2003; 2(6)581–587
   PubMed Web of Science ®Google Scholar
• Mardor Y, Roth Y, Ochershvilli A, Spiegelmann R, Tichler T, Daniels D, Maier SE, Nissim O, Ram Z, Baram J, et al. Pretreatment prediction of brain tumors' response to radiation therapy using high b-value diffusion-weighted MRI. Neoplasia 2004; 6(2)136–142
   PubMed Web of Science ®Google Scholar
• Dzik-Jurasz A, Domenig C, George M, Wolber J, Padhani A, Brown G, Doran S. Diffusion MRI for prediction of response of rectal cancer to chemoradiation. Lancet 2002; 360(9329)307–308
   PubMed Web of Science ®Google Scholar
• Kremser C, Judmaier W, Hein P, Griebel J, Lukas P, de Vries A. Preliminary results on the influence of chemoradiation on apparent diffusion coefficients of primary rectal carcinoma measured by magnetic resonance imaging. Strahlenther Onkol 2003; 179(9)641–649
   PubMed Web of Science ®Google Scholar
• Hein PA, Kremser C, Judmaier W, Griebel J, Pfeiffer KP, Kreczy A, Hug EB, Lukas P, DeVries AF. Diffusion-weighted magnetic resonance imaging for monitoring diffusion changes in rectal carcinoma during combined, preoperative chemoradiation: Preliminary results of a prospective study. Eur J Radiol 2003; 45(3)214–222
   PubMed Web of Science ®Google Scholar
• DeVries AF, Kremser C, Hein PA, Griebel J, Krezcy A, Ofner D, Pfeiffer KP, Lukas P, Judmaier W. Tumor microcirculation and diffusion predict therapy outcome for primary rectal carcinoma. Int J Radiat Oncol Biol Phys 2003; 56(4)958–965
   PubMed Web of Science ®Google Scholar
• Cui Y, Zhang XP, Sun YS, Tang L, Shen L. Apparent diffusion coefficient: Potential imaging biomarker for prediction and early detection of response to chemotherapy in hepatic metastases. Radiology 2008; 248(3)894–900
   PubMed Web of Science ®Google Scholar
• Harry VN, Semple SI, Gilbert FJ, Parkin DE. Diffusion-weighted magnetic resonance imaging in the early detection of response to chemoradiation in cervical cancer. Gynecol Oncol 2008; 111(2)213–220
   PubMed Web of Science ®Google Scholar
• Okuma T, Matsuoka T, Yamamoto A, Hamamoto S, Nakamura K, Inoue Y. Assessment of early treatment response after CT-guided radiofrequency ablation of unresectable lung tumours by diffusion-weighted MRI: A pilot study. Br J Radiol 2009; 82(984)989–994
   PubMed Web of Science ®Google Scholar
• Reichardt W, Juettner E, Uhl M, Elverfeldt DV, Kontny U. Diffusion-weighted imaging as predictor of therapy response in an animal model of Ewing sarcoma. Invest Radiol 2009; 44(5)298–303
   PubMed Web of Science ®Google Scholar
• Whittaker CS, Coady A, Culver L, Rustin G, Padwick M, Padhani AR. Diffusion-weighted MR imaging of female pelvic tumors: A pictorial review. Radiographics 2009; 29(3)759–74, discussion 74-78
   PubMed Web of Science ®Google Scholar
• Theilmann RJ, Borders R, Trouard TP, Xia G, Outwater E, Ranger-Moore J, Gillies RJ, Stopeck A. Changes in water mobility measured by diffusion MRI predict response of metastatic breast cancer to chemotherapy. Neoplasia 2004; 6(6)831–837
   PubMed Web of Science ®Google Scholar
• Pickles MD, Gibbs P, Lowry M, Turnbull LW. Diffusion changes precede size reduction in neoadjuvant treatment of breast cancer. Magn Reson Imaging 2006; 24(7)843–847
   PubMed Web of Science ®Google Scholar
• Yankeelov TE, Lepage M, Chakravarthy A, Broome EE, Niermann KJ, Kelley MC, Meszoely I, Mayer IA, Herman CR, McManus K, et al. Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer: Initial results. Magn Reson Imaging 2007; 25(1)1–13
   PubMed Web of Science ®Google Scholar
• Ma B, Meyer CR, Pickles MD, Chenevert TL, Bland PH, Galban CJ, Rehemtulla A, Turnbull LW, Ross BD. Voxel-by-voxel functional diffusion mapping for early evaluation of breast cancer treatment. Inf Process Med Imaging 2009; 21: 276–287
   PubMedGoogle Scholar
• Chen J, Daniel BL, Diederich CJ, Bouley DM, van den Bosch MA, Kinsey AM, Sommer G, Pauly KB. Monitoring prostate thermal therapy with diffusion-weighted MRI. Magn Reson Med 2008; 59(6)1365–1372
   PubMed Web of Science ®Google Scholar
• Ohira T, Okuma T, Matsuoka T, Wada Y, Nakamura K, Watanabe Y, Inoue Y. FDG-MicroPET and diffusion-weighted MR image evaluation of early changes after radiofrequency ablation in implanted VX2 tumors in rabbits. Cardiovasc Intervent Radiol 2009; 32(1)114–120
   PubMed Web of Science ®Google Scholar
• Liney GP, Gibbs P, Hayes C, Leach MO, Turnbull LW. Dynamic contrast-enhanced MRI in the differentiation of breast tumors: User-defined versus semi-automated region-of-interest analysis. J Magn Reson Imaging 1999; 10(6)945–949
   PubMed Web of Science ®Google Scholar
• Schnall MD. An overview of interpretation strategies for breast MR imaging. Magn Reson Imaging Clin N Am 2001; 9(2)289–294, v-vi
   PubMedGoogle Scholar
• Kuhl CK, Mielcareck P, Klaschik S, Leutner C, Wardelmann E, Gieseke J, Schild HH. Dynamic breast MR imaging: Are signal intensity time course data useful for differential diagnosis of enhancing lesions?. Radiology 1999; 211(1)101–110
   PubMed Web of Science ®Google Scholar
• Helbich TH. Contrast-enhanced magnetic resonance imaging of the breast. Eur J Radiol 2000; 34(3)208–219
   PubMed Web of Science ®Google Scholar
• Hayes C, Padhani AR, Leach MO. Assessing changes in tumour vascular function using dynamic contrast-enhanced magnetic resonance imaging. NMR Biomed 2002; 15(2)154–163
   PubMed Web of Science ®Google Scholar
• Parker GJ, Suckling J, Tanner SF, Padhani AR, Revell PB, Husband JE, Leach MO. Probing tumor microvascularity by measurement, analysis and display of contrast agent uptake kinetics. J Magn Reson Imaging 1997; 7(3)564–574
   PubMed Web of Science ®Google Scholar
• Tanner C, Schnabel JA, Hill DL, Hawkes DJ, Degenhard A, Leach MO, Hose DR, Hall-Craggs MA, Usiskin SI. Quantitative evaluation of free-form deformation registration for dynamic contrast-enhanced MR mammography. Med Phys 2007; 34(4)1221–1233
   PubMed Web of Science ®Google Scholar
• Li X, Dawant BM, Welch EB, Chakravarthy AB, Freehardt D, Mayer I, Kelley M, Meszoely I, Gore JC, Yankeelov TE. A nonrigid registration algorithm for longitudinal breast MR images and the analysis of breast tumor response. Magn Reson Imaging 2009; 27(9)1258–1270
   PubMed Web of Science ®Google Scholar
• Ludemann L, Prochnow D, Rohlfing T, Franiel T, Warmuth C, Taupitz M, Rehbein H, Beyersdorff D. Simultaneous quantification of perfusion and permeability in the prostate using dynamic contrast-enhanced magnetic resonance imaging with an inversion-prepared dual-contrast sequence. Ann Biomed Eng 2009; 37(4)749–762
   PubMed Web of Science ®Google Scholar
• Matsumoto S, Yasui H, Batra S, Kinoshita Y, Bernardo M, Munasinghe JP, Utsumi H, Choudhuri R, Devasahayam N, Subramanian S, et al. Simultaneous imaging of tumor oxygenation and microvascular permeability using Overhauser enhanced MRI. Proc Natl Acad Sci U S A 2009; 106(42)17898–17903
   PubMed Web of Science ®Google Scholar